Vlad Radulescu, MD

7/1/22 → 6/30/24

Project: Research project

FY24 Adult/Pediatric Hemophilia Treatment Center Services: Nursing Professional Services

7/1/22 → 6/30/24

Project: Research project

FY24 Adult/Pediatric Hemophilia Treatment Center Services: Social Work Services

7/1/22 → 6/30/24

Project: Research project

FY24 Metabolic Newborn Screening

Zarate, Y., Day, S., Fowlkes, J., Kahler, S., Kanga, J., Radulescu, V. & Wurth, M.

7/1/22 → 6/30/24

Project: Research project

FY23 Metabolic Newborn Screening

Zarate, Y., Day, S., Fowlkes, J., Kahler, S., Kanga, J., Radulescu, V. & Wurth, M.

7/1/22 → 6/30/23

Project: Research project

FY23 Adult/Pediatric Hemophilia Treatment Center Services: Social Work Services

7/1/22 → 6/30/23

Project: Research project

FY23 Adult/Pediatric Hemophilia Treatment Center Services: Administrative Assistant

7/1/22 → 6/30/23

Project: Research project

FY23 Adult/Pediatric Hemophilia Treatment Center Services: Nursing Professional Services

7/1/22 → 6/30/23

Project: Research project

FY23 Adult/Pediatric Hemophilia Treatment Center Services: Nursing Professional Services

7/1/22 → 7/1/22

Project: Research project

Hemophilia Treatment Centers (SPRANS) FY24

6/1/22 → 6/1/23

Project: Research project

Hemophilia Treatment Centers (SPRANS) FY24

6/1/22 → 5/31/24

Project: Research project

Program Income: Hemophilia Treatment Centers (HTC) FY24

6/1/22 → 5/31/24

Project: Research project

Program Income: Hemophilia Treatment Centers (HTC) FY24

Childrens Oncology Group Foundation Incorporated

6/1/22 → 6/1/23

Project: Research project

Residual Scope: St. Baldrick's Foundation Supplement Per Case Reimbursement

Badgett, J., Radulescu, V. & Wagner, L.

1/1/22 → 12/31/23

Project: Research project

AALL1331: Risk-Stratified Randomized Phase III Testing of Blinatumomab in First Relapse of Childhood B-Lymphoblastic Leukemia

Badgett, J., Radulescu, V. & Wagner, L.

5/15/21 → 8/30/24

Project: Research project

ANHL1131: Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy in High Risk Patients

Badgett, J., Radulescu, V. & Wagner, L.

5/15/21 → 4/15/22

Project: Research project

Community Counts: Public Health Surveillance for the Prevention of Complications of Bleeding Disorders

University of North Carolina Chapel Hill

9/30/20 → 9/29/22

Project: Research project

Community Counts: Public Health Surveillance for the Prevention of Complications of Bleeding Disorders

University of North Carolina Chapel Hill

9/30/20 → 9/29/21

Project: Research project

Community Counts: Public Health Surveillance for the Prevention of Complications of Bleeding Disorders

University of North Carolina Chapel Hill

9/30/20 → 9/29/23

Project: Research project

FY21 Adult/Pediatric Hemophilia Treatment Center Services: Nursing Professional Services

7/1/20 → 6/30/21

Project: Research project

FY22 Adult/Pediatric Hemophilia Treatment Center Services: Nursing Professional Services

7/1/20 → 6/30/22

Project: Research project

FY22 UK Metabolic Newborn Screening

Day, S., Fowlkes, J., Kahler, S., Kanga, J., Radulescu, V. & Wurth, M.

7/1/20 → 6/30/22

Project: Research project

FY22 Adult/Pediatric Hemophilia Treatment Center Services: Social Work Services

7/1/20 → 6/30/22

Project: Research project

FY21 Adult/Pediatric Hemophilia Treatment Center Services: Administrative Assistant

7/1/20 → 6/30/21

Project: Research project

FY21 Adult/Pediatric Hemophilia Treatment Center Services: Social Work Services

7/1/20 → 6/30/21

Project: Research project

FY22 Adult/Pediatric Hemophilia Treatment Center Services: Administrative Assistant

7/1/20 → 6/30/22

Project: Research project

FY21 UK Metabolic Newborn Screening

Day, S., Kahler, S., Kanga, J., Radulescu, V., Thrailkill, K. & Wurth, M.

7/1/20 → 6/30/21

Project: Research project

AHOD1822: An Open-Label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults with Newly Diagnosed Classical Hodgkin Lymphoma with Inadequate (Slow Early) Response to Frontline Chemotherapy (KEYNOTE 667)

Badgett, J., Bayliff, S., D'Orazio, J., Geil, J., Sorge, C., Radulescu, V. & Shaw, A.

12/4/19 → 2/15/23

Project: Research project

ALTE1631: Web-based Physical Activity Intervention for Children with ALL

12/4/19 → 8/23/24

Project: Research project

Residual Scope: Web-based Physical Activity Intervention for Children with ALL

12/4/19 → 8/23/24

Project: Research project

An Open-Label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults with Newly Diagnosed Classical Hodgkin Lymphoma with Inadequate (Slow Early) Response to Frontline Chemotherapy (KEYNOTE 667)

Badgett, J., Bayliff, S., D'Orazio, J., Geil, J., Sorge, C., Radulescu, V. & Shaw, A.

12/4/19 → 3/9/22

Project: Research project

Web-based Physical Activity Intervention for Children with ALL

12/4/19 → 10/4/21

Project: Research project

A Phase III Randomized, Open label, Multi-Center Study of the Safety and Efficacy of Apixaban for Thromboembolism Prevention versus No Systemic Anticoagulant Prophylaxis during Induction Chemotherapy in Children with Newly Diagnosed Acute Lymphoblastic

Badgett, J., Sorge, C. & Radulescu, V.

11/20/19 → 11/29/21

Project: Research project

A Phase III Randomized, Open label, Multi-Center Study of the Safety and Efficacy of Apixaban for Thromboembolism Prevention versus No Systemic Anticoagulant Prophylaxis during Induction Chemotherapy in Children with Newly Diagnosed Acute Lymphoblastic

Badgett, J., Sorge, C. & Radulescu, V.

11/20/19 → 11/29/21

Project: Research project

A Phase 2 Study of Inotuzumab Ozogamicin in Children and Young Adults with Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)

9/17/19 → 1/13/22

Project: Research project

A Phase III Study of 131I Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma (NBL)

8/9/19 → 12/9/21

Project: Research project

ANBL1531: A Phase III Study of 131I Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma (NBL)

8/9/19 → 8/10/24

Project: Research project

Residual Scope: A Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients

Badgett, J., Bayliff, S., D'Orazio, J., Geil, J., Radulescu, V., Shaw, A. & Sorge, C.

6/28/19 → 11/10/22

Project: Research project

A Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphobl

Badgett, J., Bayliff, S., D'Orazio, J., Geil, J., Radulescu, V., Shaw, A. & Sorge, C.

6/28/19 → 1/13/22

Project: Research project

AALL0434: Intensified Methotrexate, Nelarabine (Compound 506U78; NCI IND #52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-cell Acute Lymphoblastic Leukemia ALL) or T-cell Lymphoblastic Lymphoma

11/28/18 → 8/30/24

Project: Research project

Intensified Methotrexate, Nelarabine (Compound 506U78; NCI IND #52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-cell Acute Lymphoblastic Leukemia ALL) or T-cell Lymphoblastic Lymphoma

11/28/18 → 1/11/22

Project: Research project

FY20 Metabolic Newborn Screening

Psychogios, A., Fowlkes, J., Kanga, J., Radulescu, V. & Wurth, M.

7/1/18 → 6/30/20

Project: Research project

FY 19/20: UK Hemophilia Treatment Center: Social Work Services

7/1/18 → 6/30/19

Project: Research project

FY20 UK Hemophilia Treatment Center: Social Work Services

7/1/18 → 6/30/20

Project: Research project

FY20 UK Hemophilia Treatment Center: Administrative Assistant

7/1/18 → 6/30/20

Project: Research project

FY20 UK Hemophilia Treatment Center: Nursing Professional Services

7/1/18 → 6/30/20

Project: Research project

FY 19/20: UK Hemophilia Treatment Center: Administrative Assistant

7/1/18 → 6/30/19

Project: Research project

FY 19/20: UK Hemophilia Treatment Center

7/1/18 → 6/30/19

Project: Research project

Project:EveryChild A Registry, Eligibility Screening, Biology and Outcome Study